We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
-13.06%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$340M
AUM Growth
-$218M
Cap. Flow
-$143M
Cap. Flow %
-42.21%
Top 10 Hldgs %
34.54%
Holding
111
New
25
Increased
14
Reduced
28
Closed
40

Top Buys

Rank Stock Value
1
COUP
Coupa Software Incorporated
COUP
+$4.05M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.23M
3
VMC icon
Vulcan Materials
VMC
+$3.14M
4
VNDA icon
Vanda Pharmaceuticals
VNDA
+$3.06M
5
IRTC icon
iRhythm Holdings
IRTC
+$2.54M

Top Sells

Rank Stock Value
1
HUBS icon
HubSpot
HUBS
+$9.06M
2
SHAK icon
Shake Shack
SHAK
+$6.55M
3
PVTL
Pivotal Software, Inc.
PVTL
+$6.46M
4
WWE
World Wrestling Entertainment
WWE
+$5.8M
5
ECYT
Endocyte, Inc. Common Stock
ECYT
+$5.42M

Sector Composition

Rank Sector Weight
1 Healthcare 35.3%
2 Technology 15.08%
3 Communication Services 7.07%
4 Consumer Discretionary 6.11%
5 Materials 2.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WWE
101
CALL
DELISTED
World Wrestling Entertainment
WWE
– –
-155,000
Closed -$15M
WWE
102
DELISTED
World Wrestling Entertainment
WWE
– –
-60,000
Closed -$5.8M
ARNA
103
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-25,000
Closed -$1.15M
GRUB
104
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
– –
-16,000
Closed -$4.44M
GWPH
105
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-29,000
Closed -$5.01M
MNTA
106
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-95,000
Closed -$2.5M
MDCO
107
DELISTED
Medicines Co
MDCO
– –
-20,000
Closed -$465K
PVTL
108
DELISTED
Pivotal Software, Inc.
PVTL
– –
-330,000
Closed -$6.46M
NVTR
109
DELISTED
Nuvectra Corporation Common Stock
NVTR
– –
-10,000
Closed -$220K
ECYT
110
DELISTED
Endocyte, Inc. Common Stock
ECYT
– –
-305,000
Closed -$5.42M
ATVI
111
DELISTED
Activision Blizzard
ATVI
– –
-24,000
Closed -$2M
1 2 3 4
5

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
RIM
Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
Legacy Financial Group (Iowa)
Legacy Financial Group (Iowa) Des Moines, Iowa $795M AUM 12.87% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
SC
Soundwatch Capital Rowayton, Connecticut $793M AUM 15.45% 1-Year Est. Return

Atika Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Atika Capital Management held 111 positions worth $340M, down 39% from $558M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Atika Capital Management withdrew a net $143M in Q4 2018, closing 40 positions and reducing 28 holdings. Its most notable exit was HubSpot, an estimated $9.06M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 37% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Atika Capital Management opened a new position in Coupa Software Incorporated worth $4.02M.

  • Atika Capital Management's largest Q4 2018 buy was Coupa Software Incorporated: 64,000 shares worth $4.02M.
  • Atika Capital Management added most to eHealth in Q4 2018, an estimated $2.5M increase.
  • Atika Capital Management's biggest Q4 2018 reduction was NovoCure, cutting an estimated $4.99M.
  • Atika Capital Management fully exited HubSpot in Q4 2018, selling an estimated $9.06M.
  • Atika Capital Management's ten largest holdings make up 35% of its $340M portfolio in Q4 2018.
  • Atika Capital Management opened 25 new positions and closed 40 in Q4 2018.
  • Atika Capital Management's portfolio value fell 39% quarter-over-quarter to $340M.

Based on Atika Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.